IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 1 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,000 | -75.0% | 15,400 | -6.6% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 16,495 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -16.7% | 16,495 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | 0.0% | 16,495 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -25.0% | 16,495 | 0.0% | 0.00% | – |
| Q2 2015 | $8,000 | -11.1% | 16,495 | -10.8% | 0.00% | – |
| Q1 2015 | $9,000 | -43.8% | 18,495 | -11.9% | 0.00% | – |
| Q4 2014 | $16,000 | -30.4% | 20,995 | -18.0% | 0.00% | – |
| Q3 2014 | $23,000 | -86.1% | 25,601 | -82.8% | 0.00% | – |
| Q2 2014 | $166,000 | +238.8% | 149,056 | +268.0% | 0.00% | – |
| Q1 2014 | $49,000 | -10.9% | 40,506 | -31.8% | 0.00% | – |
| Q4 2013 | $55,000 | -21.4% | 59,365 | +116.7% | 0.00% | – |
| Q3 2013 | $70,000 | -46.2% | 27,396 | -59.2% | 0.00% | – |
| Q2 2013 | $130,000 | – | 67,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|